MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SR3335

CAS No. : 293753-05-6

MCE 国际站：SR3335

产品活性：SR3335 (ML 176) 是选择性的 RORα 反向激动剂，可直接结合 RORα，K_i为 220 nM。

研究领域：Metabolic Enzyme/Protease  |  Vitamin D Related/Nuclear Receptor

作用靶点：ROR

In Vitro: SR3335 is a selective RORα partial inverse agonist. In a biochemical radioligand binding assay using [³H]25-hydroxycholesterol as a label it is clear that unlabeled SR3335 dose-dependently competes for binding to the RORα LBD. The K_i is calculated as 220 nM using the Cheng-Prusoff equation. In a cell-based chimeric receptor Gal4 DNA-binding domain-NR ligand binding domain cotransfection assay, SR3335 significantly inhibits the constitutive transactivation activity of RORα (IC₅₀=480 nM)(partial inverse agonist activity), but has no effect on the activity of LXRα and RORγ.
?SR3335 suppresses the expression of endogenous RORα target genes in HepG2 cells that are involved in hepatic gluconeogenesis including glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK).
?SR3335 also blocks IL-25 and IL-33-induced ILC2 proliferation and IL-13 production ex vivo.

In Vivo: SR3335 displays reasonable exposure following an i.p. injection into mice. The ability of SR3335 is assessed to suppress gluconeogenesis using a diet-induced obesity (DIO) mouse model where the mice where treated with 15 mg/kg b.i.d., i.p. for 6-days followed by a pyruvate tolerance test. SR3335 treated mice displays lower plasma glucose levels following the pyruvate challenge consistent with suppression of gluconeogenesis. Importantly, mice treated with SR3335 displayed no difference in body weight or food intake after 7-days of treatment with SR3335.
SR3335 (15 mg/kg/day; ip for 7 days) reduces rhinovirus (RV)-induced lung ILC2s in immature mice (RV infection of 6-day-old BALB/c mice).

相关产品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Anti-diabetic Compound Library  |  Transcription Factor-Targeted Library  |  Targeted Diversity Library  |  Nuclear Receptor Compound Library  |  Heterocyclic Compound Library  |  Highly Selective Inhibitors Library  |  Methyl-3β-hydroxycholenate  |  Bevurogant  |  PF-06747711  |  Zilovertamab  |  XY101  |  RORγt inhibitor 2  |  RORγt Inverse agonist 8  |  RORγt agonist 3  |  RORγt modulator 2  |  SR0987  |  AZD-0284  |  RORγt Inverse agonist 6  |  ARN-6039  |  RORγ agonist 1  |  RORγt/DHODH-IN-2  |  SR1001  |  3-Oxo-5β-cholanoic acid  |  GNE-6468  |  RORγt inverse agonist 29  |  7ß,27-Dihydroxycholesterol  |  Nobiletin  |  CD12681  |  BMS-986251  |  TAK-828F  |  RORγt inverse agonist 13  |  RORγt Inverse agonist 3  |  SHR168442  |  GSK805  |  SR1555

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

货号: HY-14413

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。